Advertisement

Topics

Fx Shoulder to begin US FDA approved IDE study on Easytech Reversed Stemless

13:20 EST 7 Dec 2018 | PharmaBiz

FX Shoulder US, Inc. will begin the US Food and Drug Administration (FDA) approved Investigational Device Exemption (IDE) clinical study of the Easytech Reversed stemless, a shoulder prosthesis, with its first implantation scheduled for December.

Original Article: Fx Shoulder to begin US FDA approved IDE study on Easytech Reversed Stemless

NEXT ARTICLE

More From BioPortfolio on "Fx Shoulder to begin US FDA approved IDE study on Easytech Reversed Stemless"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Joint Disorders
A joint is where two or more bones come together, like the knee, hip, elbow, or shoulder. Joints can be damaged by many types of injuries or diseases, including Arthritis - inflammation of a joint causes pain, stiffness, and swelling with ...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...